Asymptomatic Mitral Regurgitation: When to Operate?

G. Mudge

DOI: https://doi.org/10.1111/j.1540-8191.1994.tb00936.x

IF: 1.778

1994-03-01

Journal of Cardiac Surgery

Abstract:The timing of surgical intervention in asymptomatic or mildly symptomatic patients with mitral regurgitation has always been a difficult clinical dilemma, especially with current options of valve replacement or valve repair. Symptomatic status should be carefully assessed and may depend upon either atrial fibrillation or progressive left ventricular dysfunction. Many patients may claim to be asymptomatic, but have profound limitations to their functional capacity and impairment of contraction indices. Because of this, every effort should be made to objectively follow the asymptomatic patient and schedule surgical intervention before irreversible left ventricular dysfunction. Left ventricular ejection fraction continues to be an inappropriate parameter, for the regurgitant fraction increases the preload to the left ventricle, and the regurgitant orifice reduces left ventricular after load with increase In ejection fraction. End‐diastolic dimension of volume is dependent upon such preload, and hence not accurate. End‐systolic diameter is a better prognostic index; an end‐systolic dimension of 4.5 cm (2.6 cm/m2) and a calculated end‐systolic volume of 50 mL/m2 seem to be reasonable discriminators of outcome following surgery. More recent investigations suggest that left ventricular dP/dt, measured from a Doppler profile of mitral regurgitation, is perhaps a better predictor. In the asymptomatic patient, it is difficult to justify a role for intense medical therapy. The patient who develops atrial fibrillation does require a long‐term anticoagulation therapy, and valve repair might be considered in this patient. Sinus rhythm may be restored with early surgical intervention, thereby reducing complications of throm‐boemboiism or anticoagulant therapy. But there is little evidence that the atrial dysrhythmia predisposes to progressive left Ventricular dysfunctlon. Vasodilator therapy In asymptomatic patients may delay the progression of left ventricular dysfunction in aortic regurgitation, but there is little evidence that such therapy in patients with mitral regurgitation will delay left ventricular dysfunction and surgical intervention. (J Card Surg 1994;9[Suppl]:248–251)